Skip to main content
Columbia University in the City of New York
Columbia University
Technology Ventures
Search
All
Technologies
General Information
For Inventors
Submit an Invention Report
Develop Your Innovation
Start a Company
SBIR / STTR Awards
IP and Entrepreneurship Language for Grant Applications
Columbia Lab-to-Market Accelerator Network
Request a Material Transfer or Confidentiality Agreement
Review Inventor Policies
Executives In Residence
Funding Opportunities
Columbia Commercialization & Entrepreneurial Resources
For Industry
Search Available Technologies
Software Express Licenses
Select Emerging Startups
Collaborate With Columbia Researchers
Start the Licensing Process
Search Available Technologies
All Available Technologies
COVID-19 Projects at Columbia
Lab-to-Market
About CTV
Technology Transfer at Columbia
CTV Fellows Program
Meet Our Team
Careers
Forms
Invention Report Form
Material Transfer Agreement Forms
CDA/NDA Request Form
Sponsored Research Agreement
Faculty Handbook IP Policy
News and Events
News
Events
Subscribe
Media
Videos
Podcast
You are here
Home
Secondary Section
News and Events
Latest News
Latest News
June 03, 2021
Salvaging 'ugly fruit': After a series of protein degradation bets, Versant turns to protein stabilization platform out of Columbia
more
June 01, 2021
Forkhead BioTherapeutics Awarded NIH SBIR Phase II Grant
more
May 27, 2021
Relativity Acquires Text IQ to Drive Leadership in AI for e-Discovery, Compliance and Privacy
more
May 20, 2021
RenBio Completes $24 Million Series A Financing and Licenses Novel SARS-CoV-2 Bispecific Antibody from Columbia University
more
April 15, 2021
Columbia launches diversity program to bring underrepresented into life science entrepreneurship
more
March 17, 2021
Newly formed UTLP aims to streamline tech licensing by pooling patents
more
February 15, 2021
From dorm rooms to board rooms: How universities are promoting entrepreneurship
more
February 13, 2021
15 Leading Research Universities Launch Joint Technology Licensing Program
more
February 09, 2021
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
more
February 05, 2021
Vor Biopharma Announces Pricing of Initial Public Offering
more
Load more
